Location History:
- Izmir, TR (2006)
- Alsancak, TR (2011)
Company Filing History:
Years Active: 2006-2011
Title: The Innovative Contributions of Safiye N Atabey
Introduction
Safiye N Atabey is a prominent inventor based in Alsancak, Turkey. She has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. With a total of 2 patents, her work focuses on innovative methods to inhibit cell motility and angiogenesis, which are critical processes in cancer progression.
Latest Patents
Atabey's latest patents include groundbreaking methods for inhibiting cell motility and angiogenesis. One patent discloses methods of inhibiting cell motility by targeting the binding between intracellular transducers and receptor protein tyrosine kinases. This method specifically addresses hepatocyte growth factor (HGF) induced cell motility. Additionally, her invention provides a means to inhibit angiogenesis using peptides such as phosphotyrosyl mimetics. These methods are aimed at preventing and treating various diseases, particularly metastatic cancers like melanoma and prostate cancer. Another patent further explores the inhibition of cell motility and angiogenesis through inhibitors of Grb2-SH2-domain, employing similar techniques to block HGF, VEGF, or bFGF-stimulated migration and cell proliferation.
Career Highlights
Safiye N Atabey is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to contribute to significant advancements in cancer research and treatment methodologies.
Collaborations
Atabey has collaborated with notable colleagues, including Donald P Bottaro and Jesus V Soriano. These partnerships have enhanced her research efforts and expanded the impact of her inventions in the scientific community.
Conclusion
Safiye N Atabey's innovative work in the field of cancer research exemplifies her dedication to improving treatment options for patients. Her patents reflect a commitment to advancing medical science and addressing critical health challenges.